HomeOCEA • NASDAQ
add
Ocean Biomedical Inc
Previous close
$0.42
Day range
$0.34 - $0.45
Year range
$0.34 - $7.79
Market cap
11.96M USD
Avg Volume
449.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Investing.com
2 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.65%
0.26%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 768.00K | -71.07% |
Net income | -5.53M | 60.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 1.13M | 9.80% |
Total liabilities | 99.22M | 30.11% |
Total equity | -98.08M | — |
Shares outstanding | 34.87M | — |
Price to book | -0.15 | — |
Return on assets | -128.73% | — |
Return on capital | 2.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.53M | 60.76% |
Cash from operations | -885.00K | 21.68% |
Cash from investing | — | — |
Cash from financing | 896.00K | — |
Net change in cash | 11.00K | 100.97% |
Free cash flow | 1.62M | 294.11% |
About
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Founded
2019
Headquarters
Website
Employees
7
